(Q46926502)

English

An open trial of paroxetine for the "offensive subtype" of taijin kyofusho and social anxiety disorder

scientific article published in January 2006

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16456863

An open trial of paroxetine for the "offensive subtype" of taijin kyofusho and social anxiety disorder (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16456863

taijin kyofusho

1 reference

based on heuristic

inferred from title

author name string

Toshihiko Nagata

1

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16456863

Irene van Vliet

2

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16456863

Hisashi Yamada

3

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16456863

Kouhei Kataoka

4

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16456863

Toshiya Iketani

5

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16456863

Nobuo Kiriike

6

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16456863

publication date

1 January 2006

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16456863

Depression and Anxiety

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16456863

23

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16456863

3

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16456863

168-174

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16456863

An Inventory for Measuring Depression

1 reference

https://api.crossref.org/works/10.1002%2FDA.20153

21 January 2018

The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability

1 reference

https://api.crossref.org/works/10.1002%2FDA.20153

21 January 2018

Social phobia. Review of a neglected anxiety disorder

1 reference

https://api.crossref.org/works/10.1002%2FDA.20153

21 January 2018

Body dysmorphic disorder: a guide for primary care physicians

1 reference

https://api.crossref.org/works/10.1002%2FDA.20153

21 January 2018

Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms.

1 reference

https://api.crossref.org/works/10.1002%2FDA.20153

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDA.20153

21 January 2018

Pharmacotherapy of social anxiety disorder

1 reference

https://api.crossref.org/works/10.1002%2FDA.20153

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of symptoms of body dysmorphic disorder and its correlates: a cross-cultural comparison

1 reference

https://api.crossref.org/works/10.1002%2FDA.20153

7 January 2021

based on heuristic

inferred from DOI database lookup

Psychometric properties of the Social Phobia Inventory (SPIN). New self-rating scale

1 reference

https://api.crossref.org/works/10.1002%2FDA.20153

7 January 2021

based on heuristic

inferred from DOI database lookup

Insight in obsessive compulsive disorder and body dysmorphic disorder

1 reference

https://api.crossref.org/works/10.1002%2FDA.20153

7 January 2021

based on heuristic

inferred from DOI database lookup

Core symptom pattern of social phobia

1 reference

https://api.crossref.org/works/10.1002%2FDA.20153

7 January 2021

based on heuristic

inferred from DOI database lookup

Social phobia among university students and its relation to self-esteem and body image

1 reference

https://api.crossref.org/works/10.1002%2FDA.20153

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical practice. Obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1002%2FDA.20153

7 January 2021

based on heuristic

inferred from DOI database lookup

Cultural factors in social anxiety: a comparison of social phobia symptoms and Taijin kyofusho

1 reference

https://api.crossref.org/works/10.1002%2FDA.20153

7 January 2021

based on heuristic

inferred from DOI database lookup

Development and validation of measures of social phobia scrutiny fear and social interaction anxiety.

1 reference

https://api.crossref.org/works/10.1002%2FDA.20153

7 January 2021

based on heuristic

inferred from DOI database lookup

History of childhood sexual or physical abuse in Japanese patients with eating disorders: relationship with dissociation and impulsive behaviours

1 reference

https://api.crossref.org/works/10.1002%2FDA.20153

7 January 2021

based on heuristic

inferred from DOI database lookup

Open trial of milnacipran for Taijin-Kyofusho in Japanese patients with social anxiety disorder

1 reference

https://api.crossref.org/works/10.1002%2FDA.20153

7 January 2021

based on heuristic

inferred from DOI database lookup

Reliability and validity of the Japanese version of the Yale-Brown Obsessive-Compulsive Scale

1 reference

https://api.crossref.org/works/10.1002%2FDA.20153

7 January 2021

based on heuristic

inferred from DOI database lookup

The neurotic versus delusional subtype of taijin-kyofu-sho: their DSM diagnoses

1 reference

https://api.crossref.org/works/10.1002%2FDA.20153

7 January 2021

based on heuristic

inferred from DOI database lookup

Change in personality status in neurotic disorders.

1 reference

https://api.crossref.org/works/10.1002%2FDA.20153

7 January 2021

based on heuristic

inferred from DOI database lookup

Social phobia syndrome in Japan

1 reference

https://api.crossref.org/works/10.1002%2FDA.20153

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/DA.20153

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16456863

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16456863

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46926502&oldid=2167335163"